e-learning
resources
Amsterdam 2015
Tuesday, 29.09.2015
Thoracic oncology around the world: rare cases and local features
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Treatment and survival in patients with pulmonary carcinoid tumours; an updated analysis from the UK national lung cancer audit
Stephanie Hobbins (West Midlands, United Kingdom), Stephanie Hobbins, Paul Beckett, Michael Peake, Ian Woolhouse
Source:
International Congress 2015 – Thoracic oncology around the world: rare cases and local features
Session:
Thoracic oncology around the world: rare cases and local features
Session type:
Thematic Poster Session
Number:
4298
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Stephanie Hobbins (West Midlands, United Kingdom), Stephanie Hobbins, Paul Beckett, Michael Peake, Ian Woolhouse. Treatment and survival in patients with pulmonary carcinoid tumours; an updated analysis from the UK national lung cancer audit. Eur Respir J 2015; 46: Suppl. 59, 4298
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
Improving survival for NSCLC patients in the national lung cancer audit
Source: International Congress 2015 – Quality management in lung cancer
Year: 2015
Brain metastatic recurrence following radically treated lung cancer; a retrospective analysis
Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series
Year: 2014
Impact of second-line treatment on overall survival of advanced lung adenocarcinoma patients
Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up
Year: 2016
A feasibility study of pulmonary rehabilitation at home in patients with lung cancer or malignant pleural mesothelioma treated by (radio-)chemotherapy
Source: International Congress 2014 – Best abstracts in pulmonary rehabilitation and exercise training
Year: 2014
Lung cancer in England: Trends in survival over the duration of the national lung cancer audit
Source: Annual Congress 2013 –Epidemiology of respiratory disease
Year: 2013
Second primary lung cancer in squamous NSCLC patients: The Nancy Biobank's database
Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours
Year: 2014
Clinical features and prognosis of multiple primary malignancies in patients with lung cancer
Source: Annual Congress 2013 –Other thoracic tumours, particular circumstances and rare cases
Year: 2013
Lung cancer and lung tuberculosis: Our results of treatment in the combined lung disease
Source: International Congress 2016 – Surgical strategy for complex diseases
Year: 2016
Comparative analysis of the results of surgical treatment for pulmonary metastases from colorectal cancer and metastases from other primary origin
Source: International Congress 2016 – Open problems in thoracic surgery
Year: 2016
Safety and efficacy of erlotinib in patients with squamous cell lung cancer
Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series
Year: 2014
Patient outcome and factors influencing lack of histology in patients with clinical diagnosis of lung cancer
Source: Annual Congress 2013 –Quality management in thoracic oncology
Year: 2013
Improving NLST criteria for lung cancer screening
Source: International Congress 2014 – Improving diagnosis of thoracic tumours
Year: 2014
Is there equitable access to PET-CT for lung cancer patients across a large UK cancer network; a retrospective study of 4597 patients
Source: International Congress 2015 – Quality management in lung cancer
Year: 2015
A prospective study of survival after surgery for early stage non-small cell lung cancer in patients with COPD
Source: International Congress 2015 – Risk assessment and prevention of complications in thoracic surgery
Year: 2015
Clinicopathological characteristics and treatment outcomes of pulmonary carcinosarcoma in eight patients
Source: International Congress 2015 – Thoracic oncology around the world: rare cases and local features
Year: 2015
Lung cancer after lymphoma: Disease characteristics, detection methods and clinical outcome
Source: Annual Congress 2013 –Other thoracic tumours, particular circumstances and rare cases
Year: 2013
Pulmonary function during lung cancer therapy: A retrospective analysis of patients treated with monotherapy or multimodal treatments
Source: International Congress 2016 – Clinical aspects of lung cancer
Year: 2016
Defining a standard set of patient-centered outcomes for patients with lung cancer
Source: International Congress 2015 – Quality management in lung cancer
Year: 2015
Comparing performance and cost of EBUS-TBNA versus other methods for diagnosis and staging of non-small cell lung cancer (NSCLC)
Source: International Congress 2014 – Improving diagnosis of thoracic tumours
Year: 2014
Prognostic factors for survival in lung cancer
Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept